Where to Buy Selank: Only One Channel Quotes $2.38/mg

The last column is the one that decides whether a channel can be compared at all. Two of the four price in a unit that converts cleanly. One prices in a unit that converts only if the bottle states its total mass. One does not exist as a purchasable product.

The clinic channel that exists for some compounds does not exist here: no infusion service, no published service rate, and no medical route that ends with a Selank prescription in the US.

This is where almost every US buyer ends up, and it is worth being precise about why. Not because research suppliers are trusted, but because they are the only sellers whose product carries a number you can audit: a labelled mass, a lot code, and a certificate produced by somebody else.

Ascension Peptides lists Selank at 10 mg, $60.00 struck through to $47.50, and $23.75 with the code PEPTIDEDECK. On the label that is $4.75 and $2.38 per milligram. Two certificates are published against the listing, from MZ Biolabs and Kovera Labs, and reading both is instructive because they do not test the same things.

Both lots measured heavier than the label, which moves the real rate on the code price to $1.93 and $2.00 per milligram respectively. Neither figure is promised anywhere on the listing, so treat them as results rather than terms. Read the sterility line at the strength the report claims for it, too: it calls the method a preliminary screen and notes that full compendial testing may be required for regulatory compliance. The Selank price page works that division out in full.

The gap that matters is the endotoxin row, and it exists because of what FDA has written about this compound: compounded drugs containing selank acetate may pose a risk for immunogenicity for certain routes of administration, due to the potential for aggregation and peptide-related impurities. Purity testing does not answer that. An LAL assay and a microbial screen begin to. The same reasoning drives our BPC-157 channel comparison, where the research-vial channel is likewise the only one quoting a rate.

People ask where can I buy Selank and are often told to find a compounding pharmacy. That advice is a decade out of date and misreads the regulatory record in a specific way worth correcting.

A 503A compounding pharmacy can work with a bulk drug substance if the substance is the subject of an applicable USP monograph, is a component of an FDA-approved drug, or appears on the list FDA develops for the purpose. Selank meets none of the three. It has no monograph, it is a component of no approved drug, and it is absent from every category of the 503A bulk substances list, updated 14 May 2026.

The record is more specific than mere absence. Selank acetate, which FDA names as Selank acetate (TP-7), was nominated for that list and the nomination was withdrawn. It appears on FDA's safety-risks page under substances nominated but withdrawn, not among the substances FDA identified as raising significant safety risks. That second list, Category 2, currently holds six entries: cesium chloride, domperidone, germanium sesquioxide, ibutamoren mesylate, kisspeptin-10, and quinacrine hydrochloride for intrauterine administration.

Sites claiming Selank is Category 2 or banned from compounding have it wrong, and the correction does not help a buyer. Nominated, withdrawn and unlisted leaves a compounder with no defensible position, which is why the pharmacy channel produces no product and therefore no price. Compare that with a compound sitting in Category 1: our NAD+ regulatory breakdown covers what non-enforcement pending evaluation actually permits, and it is a genuinely different situation.

Searches for where to buy Selank nasal spray land on consumer nootropic storefronts rather than peptide suppliers, and the format difference is larger than it looks.

A lyophilised vial is dry powder with a stated mass, a lot code and a certificate. A nasal spray is a solution: someone has already chosen the concentration, added whatever the formulation requires, and sealed it in a bottle with a pump. Four consequences follow, none of them about quality and all of them about what you can check.

• The unit changes. A vial is priced per milligram of peptide. A bottle is priced per bottle, and converts only if the label states total milligrams and fill volume. Many do not.
• Sterility expectations change. Dry powder is stable and inert until it meets water. A solution has a shelf life, a preservative question and a microbiological history from the moment it was mixed.
• Testing evidence usually disappears. Research suppliers publish lot-level certificates because their buyers demand them. Consumer nootropic retailers rarely publish anything comparable for a finished spray.
• The seller's claims change. A research supplier labels the product not for human consumption. A consumer retailer is often selling an experience, which is a marketing posture with regulatory consequences and no bearing on what is in the bottle.

Ascension sells the vial, not a spray, so this page cannot pretend to price the spray market against it. What it can say is that a bottle without a stated total mass cannot be compared with $2.38 per milligram in either direction, and that a comparison run on bottle price alone is not a comparison at all.

The cheapest per-vial figures for Selank come from sellers shipping internationally, and per-vial is exactly the wrong unit to judge them on.

Four costs sit outside the sticker. Carriage, which on a single vial can rival the vial. Duty and brokerage, which vary by declared value and description. Transit time, which for a lyophilised powder matters less than for a solution but is not free. And seizure, which is not a cost so much as a total loss with no return path and no chargeback that a card issuer will honour for a research chemical.

The documentation problem is more structural. A certificate emailed on request, or hosted as a single PDF with no lot code, cannot be matched to the vial you were sent. That failure is not detectable on arrival and it disables every criterion that mattered. A domestic seller publishing lot-level documents is not automatically better material, but it is checkable material, and checkability is the only thing separating a $2.38 per milligram figure from a number somebody typed.

Grey resellers, meaning individuals repackaging bulk powder into unlabelled vials, sit at the end of the same spectrum. There is no lot, no laboratory and no mass to divide by. Whatever the price, the rate is undefined.

The arithmetic is deliberately dull. Take the total you will actually pay, including carriage, and divide by the milligrams of peptide you will actually receive. Everything above becomes comparable the moment both halves are known.

The tiers work off the list price and the code works off a single vial, so the ladder never catches the code. Ten vials at the best tier still costs 80% more per milligram than one vial with the code, and getting there means committing $427.50. Free shipping starts at $250, which the five-vial tier misses by $24.37 and the ten-vial tier clears comfortably.

A bottled spray joins the table only when its label states total milligrams. An overseas vial joins it at the landed total rather than the sticker. A compounding pharmacy never joins it, because there is nothing to divide.

After that the unit changes again, from money to volume. A 10 mg vial reconstituted at 2 mL is 5 mg/mL, so one unit on a U-100 barrel holds 50 micrograms and ten units hold 500, as laboratory handling arithmetic and nothing else. The Selank calculator and our syringe measurement guide cover that conversion, and the Semax reference page is the nearest comparison point for anyone cross-shopping the two Russian nootropic heptapeptides.